4.1 Article

Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment Results From the Einstein Aging Study

期刊

ALZHEIMER DISEASE & ASSOCIATED DISORDERS
卷 30, 期 2, 页码 93-98

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WAD.0000000000000125

关键词

mild cognitive impairment; perceived stress; remediable risk factor; apolipoprotein epsilon 4

资金

  1. National Institutes of Health from National Center for Advancing Translational Sciences (NCATS) [NIA 2 P01 AG03949, NIA 1R01AG039409-01, NIA R03 AG045474, CTSA 1UL1TR001073]
  2. Leonard and Sylvia Marx Foundation
  3. Czap Foundation

向作者/读者索取更多资源

Stress is a potentially remediable risk factor for amnestic mild cognitive impairment (aMCI). Our objective is to determine whether perceived stress predicts incident aMCI and to determine if the influence of stress on aMCI is independent of known aMCI risk factors, particularly demographic variables, depression, and apolipoprotein genotype. The Einstein Aging Study is a longitudinal community-based study of older adults. The Perceived Stress Scale (PSS) was administered annually in the Einstein Aging Study to participants (N= 507; 71 developed incident aMCI; mean follow-up time= 3.6 y, SD= 2.0) who were aged 70 years and older, free of aMCI and dementia at baseline PSS administration, and had at least 1 subsequent annual follow-up. Cox hazard models were used to examine time to aMCI onset adjusting for covariates. High levels of perceived stress are associated with a 30% greater risk of incident aMCI (per 5-point increase in PSS: hazard ratio= 1.30; 95% confidence interval, 1.08-1.58) independent of covariates. The consistency of results after covariate adjustment and the lack of evidence for reverse causation in longitudinal analyses suggest that these findings are robust. Understanding of the effect of perceived stress on cognition may lead to intervention strategies that prevent the onset of aMCI and Alzheimer dementia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

The Temporal Relationship between Pain Intensity and Pain Interference and Incident Dementia

Ali Ezzati, Cuiling Wang, Mindy J. Katz, Carol A. Derby, Andrea R. Zammit, Molly E. Zimmerman, Jelena M. Pavlovic, Martin J. Sliwinski, Richard B. Lipton

CURRENT ALZHEIMER RESEARCH (2019)

Article Neurosciences

Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project

Andrea R. Zammit, Graciela Muniz-Terrera, Mindy J. Katz, Charles B. Hall, Ali Ezzati, David A. Bennett, Richard B. Lipton

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Geriatrics & Gerontology

Depressive Symptoms Predict Incident Dementia in a Community Sample of Older Adults: Results From the Einstein Aging Study

Ali Ezzati, Mindy J. Katz, Carol A. Derby, Molly E. Zimmerman, Richard B. Lipton

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2019)

Article Clinical Neurology

Health-related Quality of Life, Cognitive Performance, and Incident Dementia in a Community-based Elderly Cohort

Ali Ezzati, Andrea R. Zammit, Mindy J. Katz, Carol A. Derby, Molly E. Zimmerman, Richard B. Lipton

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2019)

Article Neuroimaging

Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI

Ali Ezzati, Andrea R. Zammit, Christian Habeck, Charles B. Hall, Richard B. Lipton

BRAIN IMAGING AND BEHAVIOR (2020)

Article Clinical Neurology

The relationship between hippocampal volume, chronic pain, and depressive symptoms in older adults

Ali Ezzati, Andrea R. Zammit, Michael L. Lipton, Richard B. Lipton

PSYCHIATRY RESEARCH-NEUROIMAGING (2019)

Article Clinical Neurology

Neuropsychological latent classes at enrollment and postmortem neuropathology

Andrea R. Zammit, Charles B. Hall, David A. Bennett, Ali Ezzati, Mindy J. Katz, Graciela Muniz-Terrera, Richard B. Lipton

ALZHEIMERS & DEMENTIA (2019)

Article Neurosciences

Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease

Ali Ezzati, Andrea R. Zammit, Danielle J. Harvey, Christian Habeck, Charles B. Hall, Richard B. Lipton

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Neurosciences

Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease

Ali Ezzati, Richard B. Lipton

JOURNAL OF ALZHEIMERS DISEASE (2020)

Article Clinical Neurology

Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia

Ali Ezzati, Ahmed Abdulkadir, Clifford R. Jack, Paul M. Thompson, Danielle J. Harvey, Monica Truelove-Hill, Lasya P. Sreepada, Christos Davatzikos, Richard B. Lipton

Summary: The study evaluated the value of the ATN biomarker classification system in predicting conversion from MCI to dementia, with data-driven approaches showing better performance in this prediction. Both classifiers using clinical features and classifiers using ATN biomarkers performed equally well in predicting progression to dementia.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study

Ali Ezzati, Kristina M. Fanning, Dawn C. Buse, Jelena M. Pavlovic, Cynthia E. Armand, Michael L. Reed, Vincent T. Martin, Richard B. Lipton

Summary: This study aims to identify predictors of acute treatment response for nonprescription medications among people with migraine and develop improved models for predicting treatment response.

HEADACHE (2022)

Article Clinical Neurology

Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study

Ali Ezzati, Dawn C. Buse, Kristina M. Fanning, Michael L. Reed, Vincent T. Martin, Richard B. Lipton

Summary: This study aimed to identify predictors of acute treatment optimization among people with episodic migraine. The results showed that men, individuals with higher average headache pain intensity, higher migraine symptom severity scores, presence of cutaneous allodynia, and depression had reduced odds of adequate 2-hour pain freedom response. Adequate 24-hour pain relief was associated with being married, but declined in those with higher-than-average average headache pain intensity and frequency, greater disability, presence of cutaneous allodynia, and depression. Participants taking triptans were more likely to have adequate treatment response compared to those taking butalbital combination medications (BCMs) and opioids. There was no significant difference in response to treatment between participants taking BCMs and opioids.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Article Clinical Neurology

Predictors of treatment-response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti-inflammatory drugs in acute treatment of episodic migraine

Ali Ezzati, Kristina M. Fanning, Michael L. Reed, Richard B. Lipton

Summary: The objective of this study was to identify predictors of acute treatment optimization for migraine with over-the-counter (OTC) medications and to develop predictive models for each class of OTC medication. The study analyzed data from 2224 participants and found that a large subgroup of people with migraine had an inadequate response to their usual OTC migraine treatment. Predictive models identified several factors associated with better treatment response in each class of OTC medication. These findings suggest a need to improve OTC treatment for some and to offer prescription acute medications for others.

HEADACHE (2023)

Article Clinical Neurology

Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals

Ellen Grober, Kellen K. Petersen, Richard B. Lipton, Jason Hassenstab, John C. Morris, Brian A. Gordon, Ali Ezzati

Summary: This study used the SOMI system to identify individuals with subtle cognitive impairment among those who appear to be cognitively normal. The results showed that participants with retrieval impairment (SOMI-1) had a higher incidence of cognitive impairment, and the risk increased even more for those with storage impairment (SOMI-3/4), after adjusting for demographics and APOE ε4 status. Additionally, the study found that SOMI remained a significant predictor of incident cognitive impairment even after considering biomarkers of β-amyloid, tau pathology, and neurodegeneration.

NEUROLOGY (2023)

Article Clinical Neurology

Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials

Ali Ezzati, Christos Davatzikos, David A. Wolk, Charles B. Hall, Christian Habeck, Richard B. Lipton

Summary: This article investigates the application of predictive models in Alzheimer's disease clinical trials to enhance the efficacy by selecting and excluding patients unlikely to show cognitive decline.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

暂无数据